Glaucoma Eye Drops Market to Witness Increasing Revenue Growth During the Forecast Period 2020–2027


Glaucoma Eye Drops is the very last resort for any eye specialist. They are a safe, affordable and effective way of controlling intraocular pressure. They are not only an extremely effective method to control intraocular pressure (IOP), but they also do not require the surgeon to make any incisions into your eye, as often occurs with other forms of surgery. These medications usually come in the form of liquid drops, of which there are many different kinds. In December 2020, a group of researchers from the Georgia Tech and Emory University developed a possible solution for glaucoma that could be an alternative for eye-surgery, and it involves administering an injection every six months in this two-year treatment.

In June 2021, Melling Medical extended its ophthalmic equipment portfolio with its ICare technology, which aims to screen, diagnose and treat glaucoma and other eye-disorders. The growing incidences of eye-related diseases including open-angle glaucoma, presbyopia, and diabetic retinopathy are projected to drive the glaucoma eye drops market expansion. Similarly, the extended screen-time on smart devices and rising cases of eye disorders in geriatric population are broadening the scope for the glaucoma eye drops market.

Read More: https://bit.ly/3yFdJl5

Comments

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027